|
Dr Kevin King
Kevin King is Senior Director of Formulation & Process Development in Biotherapeutics Pharmaceutical Sciences at Pfizer. He is a biochemist and a graduate of the University of Wales, UK and has more than 17 years experience in the development of biotherapeutics. He has worked previously at Hoffmann-La Roche, Procter & Gamble and Lonza Biologics. As Senior Director of Formulation & Process Development he leads a group of pharmaceutical scientists involved in investigating biotherapeutic formulation stabilization technologies, formulation development, delivery technologies and applying the learnings in the formulation design of Pfizer’s biotherapeutic portfolio.
|